Eyebright Medical Technology Beijing Co Ltd
SSE:688050

Watchlist Manager
Eyebright Medical Technology Beijing Co Ltd Logo
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Watchlist
Price: 98.63 CNY 1.94% Market Closed
Market Cap: 18.7B CNY
Have any thoughts about
Eyebright Medical Technology Beijing Co Ltd?
Write Note

Eyebright Medical Technology Beijing Co Ltd
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Eyebright Medical Technology Beijing Co Ltd
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Change in Working Capital
-ÂĄ360.7m
CAGR 3-Years
-50%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Change in Working Capital
ÂĄ2.7B
CAGR 3-Years
-4%
CAGR 5-Years
3%
CAGR 10-Years
N/A
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Change in Working Capital
-ÂĄ823m
CAGR 3-Years
-10%
CAGR 5-Years
-4%
CAGR 10-Years
-8%
Autobio Diagnostics Co Ltd
SSE:603658
Change in Working Capital
-ÂĄ1.5B
CAGR 3-Years
-20%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Change in Working Capital
-ÂĄ2.1B
CAGR 3-Years
-13%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Change in Working Capital
-ÂĄ1B
CAGR 3-Years
-29%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
No Stocks Found

Eyebright Medical Technology Beijing Co Ltd
Glance View

Market Cap
18.7B CNY
Industry
Health Care

Nestled in the bustling heart of Beijing, Eyebright Medical Technology Co., Ltd. stands as a beacon of innovative healthcare solutions in China. Founded with the vision of transforming patient experiences and outcomes, the company has carved a niche for itself in the ophthalmic devices sector. Eyebright's story is one of relentless pursuit of excellence, where cutting-edge technology and medical expertise converge. The company has built its reputation around developing advanced medical instruments and devices tailored specifically for eye care, addressing pressing needs in ophthalmology by enhancing diagnostic and treatment capabilities. Their products, ranging from sophisticated intraocular lenses to state-of-the-art surgical equipment, are designed to not only improve precision in surgeries but also to elevate the overall efficiency and safety of ophthalmic procedures. Eyebright Medical Technology generates its revenue through a balanced ecosystem of product sales and strategic alliances. The company leverages its robust research and development arm to continually introduce new products and update existing ones, ensuring compatibility with the latest medical standards and customer demands. Collaborating with a network of hospitals, clinics, and healthcare providers, Eyebright extends its reach across China and beyond, supplying essential ophthalmic equipment to practitioners dedicated to superior eye care. Furthermore, by maintaining strong partnerships with global optical giants, they benefit from cross-border knowledge and technology exchange, which fuels their growth trajectory. This multifaceted approach not only anchors them firmly in the healthcare landscape but also positions them advantageously in the face of ever-evolving industry challenges.

Intrinsic Value
79.45 CNY
Overvaluation 19%
Intrinsic Value
Price

See Also

What is Eyebright Medical Technology Beijing Co Ltd's Change in Working Capital?
Change in Working Capital
-360.7m CNY

Based on the financial report for Dec 31, 2023, Eyebright Medical Technology Beijing Co Ltd's Change in Working Capital amounts to -360.7m CNY.

What is Eyebright Medical Technology Beijing Co Ltd's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
-43%

Over the last year, the Change in Working Capital growth was -74%. The average annual Change in Working Capital growth rates for Eyebright Medical Technology Beijing Co Ltd have been -50% over the past three years , -43% over the past five years .

Back to Top